Should mannitol be reinstated in prevention of cisplatin-induced nephrotoxicity?
1 Department of Pharmacy, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.|2 Centre de Recherche du CHUM, Montréal, QC, Canada.
Jean-Philippe
JP
Adam
1 Department of Pharmacy, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
Marie-Andrée
MA
Fournier
1 Department of Pharmacy, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.|2 Centre de Recherche du CHUM, Montréal, QC, Canada.|3 Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada.
Nathalie
N
Letarte
D000046:Academic Medical Centers; D002945:Cisplatin; D006801:Humans; D007297:Inpatients; D007674:Kidney Diseases; D008353:Mannitol; D010045:Outpatients; D012189:Retrospective Studies
D008353:Mannitol; D002945:Cisplatin